In human glioma samples, PDGFB ChIP-seq enrichment at these loci was lowest in a recurrent mtIDH tumor and was highest in a wtIDH tumor, which suggests that loss of centromeric binding in mIDH tumors may contribute to disease progression. This evidence concerns the gene PDGFB and neoplasm.